EPC Stock Cash Flow Statements

Edgewell Personal Care Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Edgewell Personal Care Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-06-30	2014-03-31	2013-12-31	2013-06-30	2013-03-31	2012-12-31	2012-06-30	2012-03-31	2011-12-31	2011-06-30

cash flow from operating activities
net earnings	29,100,000	29,000,000	-2,100,000	8,800,000	49,000,000	36,000,000	4,800,000	31,300,000	52,500,000	19,000,000	11,900,000	33,700,000	30,500,000	23,200,000	11,200,000	44,100,000	40,800,000	14,400,000	17,700,000	21,000,000	4,700,000	19,500,000	22,400,000	21,400,000	-441,400,000	48,200,000	-400,000	19,400,000	12,100,000	65,100,000	6,700,000	-148,400,000	54,900,000	65,700,000	33,500,000	52,200,000	36,700,000	66,100,000	23,700,000	-219,400,000	-72,500,000	-88,500,000	105,100,000	64,500,000	98,500,000	107,900,000	87,200,000	84,900,000	129,800,000	70,200,000	77,900,000	143,800,000	65,900,000
depreciation and amortization	22,100,000	21,800,000	21,700,000	21,400,000	21,700,000	22,400,000	22,500,000	23,300,000	22,500,000	23,100,000	22,500,000	22,800,000	22,500,000	23,200,000	21,400,000	21,200,000	21,500,000	22,200,000	22,200,000	23,300,000	21,000,000	22,000,000	22,500,000	24,600,000	22,800,000	24,300,000	22,100,000	24,200,000	24,200,000	24,400,000	24,800,000	24,100,000	23,400,000	23,500,000	23,400,000	23,400,000	24,600,000	24,400,000	20,200,000	21,800,000	28,900,000	31,400,000	33,200,000	32,900,000	31,500,000	33,400,000	35,100,000
share-based compensation expense	6,400,000	6,300,000	6,100,000	6,100,000	7,100,000	6,300,000	7,000,000	7,700,000	6,500,000	6,800,000	6,500,000	5,400,000	6,200,000	6,700,000	5,500,000	7,700,000	7,600,000	6,700,000	5,300,000	4,100,000	4,900,000	5,300,000	4,900,000	4,000,000	3,800,000	5,100,000	4,900,000	3,000,000	4,700,000	4,500,000	4,800,000	5,600,000	5,200,000	5,700,000	5,700,000
loss on sale of assets	200,000	100,000	1,400,000	400,000	100,000	100,000	100,000	1,400,000	100,000	300,000	700,000	900,000	200,000	100,000	300,000	300,000	200,000	200,000	200,000		900,000	100,000	200,000
deferred compensation payments	-500,000	-1,700,000	-200,000	-500,000	-200,000	-1,000,000	-400,000	0	-200,000			-200,000	0	-6,600,000	-500,000	-100,000	-400,000	-8,600,000	-200,000	0	0	-6,800,000	-1,900,000	-200,000	-2,100,000			-1,300,000	-6,300,000			-300,000	-1,900,000
deferred income taxes	-400,000	-300,000	200,000	-10,900,000	1,900,000	-400,000	-200,000	-3,900,000	300,000	-800,000	-100,000	-3,100,000	-100,000	-10,400,000	-100,000	10,900,000	-500,000			13,200,000	-600,000	1,200,000	-16,700,000	-2,800,000	-56,500,000	-200,000	-100,000	25,200,000	-400,000	6,400,000	-28,900,000
other	-4,200,000	-10,300,000	2,300,000	-7,700,000	-6,000,000	-4,400,000	-600,000	-9,900,000	5,800,000	-17,600,000	-1,800,000	-5,000,000	-3,900,000	-2,600,000	1,700,000	-2,000,000	800,000	-2,600,000	1,000,000	-6,300,000	-1,600,000	3,500,000	5,400,000	-5,400,000	-4,800,000	-600,000	5,100,000	23,600,000	800,000	-100,000	-4,800,000	-3,700,000	-1,100,000	-7,000,000	-4,100,000	-3,600,000	-500,000	-16,200,000	-11,500,000	-9,200,000	-14,300,000	-18,100,000	3,700,000	-6,500,000	-19,900,000	7,100,000	-6,500,000	-15,800,000	-20,500,000	-16,700,000	-16,000,000	3,600,000	500,000
changes in operating assets and liabilities	62,100,000	200,000	-145,000,000		27,600,000	70,000,000	-106,100,000		78,900,000	54,900,000	-126,000,000		56,900,000	5,500,000	-118,500,000		104,700,000	6,100,000	-128,700,000		45,900,000	18,200,000	-78,500,000		58,800,000	-57,300,000	-78,700,000		59,800,000	2,900,000	-9,700,000
net cash from operating activities	114,800,000	45,100,000	-115,600,000	73,700,000	101,200,000			47,800,000				29,600,000				73,100,000				114,000,000				92,400,000				71,400,000	119,900,000			176,800,000				172,300,000				125,100,000	-56,100,000			149,800,000	177,800,000	51,100,000	220,100,000	178,100,000	71,600,000
cash flow from investing activities
capital expenditures	-15,500,000	-17,100,000	-16,800,000	-25,900,000	-12,600,000	-11,500,000	-6,500,000	-18,400,000	-12,300,000	-7,500,000	-11,300,000	-19,000,000	-12,400,000	-15,600,000	-9,400,000	-22,700,000	-11,900,000	-12,000,000	-10,200,000	-20,800,000	-10,100,000	-9,200,000	-7,600,000	-19,300,000	-15,800,000	-13,500,000	-9,400,000	-20,200,000	-14,200,000	-16,000,000	-11,600,000	-23,600,000	-15,000,000	-16,700,000	-13,700,000	-18,600,000	-16,400,000	-20,000,000	-14,500,000	-27,000,000	-35,400,000	-21,700,000	-15,300,000	-18,600,000	-16,100,000	-20,300,000	-21,200,000	-22,700,000	-15,400,000	-24,900,000	-33,500,000	-18,000,000	-23,100,000
free cash flows	99,300,000	28,000,000	-132,400,000	47,800,000	88,600,000			29,400,000				10,600,000				50,400,000				93,200,000				73,100,000				51,200,000	105,700,000			153,200,000				153,700,000				98,100,000	-91,500,000			131,200,000	161,700,000	30,800,000	198,900,000	155,400,000	56,200,000
collection of deferred purchase price on accounts receivable sold	3,300,000	1,200,000	1,100,000		100,000				700,000	400,000	400,000		900,000	3,900,000	800,000		400,000	700,000	1,500,000		600,000	500,000	2,800,000		4,000,000	2,500,000	2,500,000
net cash from investing activities	-12,300,000	-17,300,000	-15,700,000
cash flow from financing activities
cash proceeds from debt with original maturities greater than 90 days	169,000,000	236,000,000	369,000,000	180,000,000	248,000,000	169,000,000	216,000,000	196,000,000	232,000,000	172,000,000	241,000,000	173,000,000	135,000,000	201,000,000	198,000,000					0	0	0	50,000,000	118,000,000	63,000,000	116,000,000	137,000,000	73,000,000	172,000,000	52,000,000	253,000,000	90,000,000	0	35,000,000	146,000,000	100,000,000	261,000,000	250,500,000	144,800,000
cash payments on debt with original maturities greater than 90 days	-230,000,000	-244,000,000	-204,000,000		-309,000,000	-271,000,000	-125,000,000	-159,000,000	-323,000,000	-251,000,000	-141,000,000	-139,000,000	-193,000,000							0	0	0	-167,000,000	-126,000,000	-153,000,000	60,000,000	-105,000,000	-66,000,000	-295,000,000	-327,000,000	-100,000,000	-145,000,000	-30,000,000	-106,000,000	-287,000,000	-130,000,000	-240,000,000			0	-1,819,800,000	-200,000	-80,000,000				-125,000,000	0	-106,500,000	-436,500,000	-1,500,000	-1,500,000	-476,500,000
(payments for) proceeds from debt with original maturities of 90 days or less
repurchase of shares	-24,500,000	-35,400,000	-30,300,000	-18,300,000	-9,900,000	-15,300,000	-15,000,000	-30,000,000	-15,200,000	-15,000,000	-15,000,000	-15,200,000	-34,700,000	-50,900,000	-24,500,000	0	0	0	-9,200,000
dividends to common shareholders	-7,200,000	-7,300,000	-7,900,000		-7,500,000	-8,200,000	-7,600,000		-7,700,000	-7,800,000	-8,300,000		-8,000,000	-8,200,000	-8,500,000		-8,300,000
net financing inflow from the accounts receivable facility	13,900,000				2,900,000	-3,400,000	4,800,000																		3,300,000
employee shares withheld for taxes	0	-100,000	-7,300,000	-200,000	-100,000	0	-7,000,000	0	-900,000	0	-8,100,000	-300,000	-700,000	0	-9,700,000	-200,000	-1,000,000	0	-3,000,000	-300,000	-200,000	0	-1,500,000	-1,200,000	-300,000	0	-1,500,000	-900,000	-100,000	-100,000	-2,000,000
net cash from financing activities	-83,400,000	-37,400,000	109,900,000				69,800,000				82,900,000																24,500,000										-25,100,000	-13,900,000	63,700,000				86,900,000			33,000,000
effect of exchange rate changes on cash	10,400,000	4,200,000	-12,200,000	4,900,000	-4,200,000	-4,100,000	6,900,000	-5,700,000	700,000	3,600,000	10,000,000	-8,500,000	-7,200,000	-600,000	-3,200,000	-3,300,000	1,000,000	-4,500,000	6,400,000	3,600,000	2,600,000	-3,900,000	3,300,000	-4,900,000	2,100,000	-1,600,000	-1,700,000	500,000	-9,200,000	7,200,000	4,000,000	8,300,000	14,500,000	4,500,000	-14,300,000	1,400,000	-4,200,000	14,100,000	-8,400,000	-2,300,000	14,200,000	-47,900,000	-27,700,000	3,600,000	1,600,000	1,200,000	800,000	-21,500,000	3,500,000	-15,100,000	4,100,000	-4,600,000	5,300,000
net decrease in cash and cash equivalents	29,500,000	-5,400,000	-33,600,000			-18,000,000	-2,200,000			-28,900,000	-4,600,000			-51,700,000	-239,400,000			1,300,000	-83,900,000			57,000,000	-89,800,000						-25,100,000				52,000,000	-15,600,000	-320,400,000		31,000,000
cash and cash equivalents, beginning of period	0	0	209,100,000	0	0	0	216,400,000	0	0	0	188,700,000	0	0	0	479,200,000	0	0	0	364,700,000	0	0	0	341,600,000	0	0	0	266,400,000	0	0	0	502,900,000	0	0	0	738,900,000	0	0	0	712,100,000	0	0	0	1,129,000,000	0	0	998,300,000	0	0	718,500,000	0	0	471,200,000	0
cash and cash equivalents, end of period	29,500,000	-5,400,000	175,500,000	13,000,000	-100,000	-18,000,000	214,200,000	9,000,000	52,200,000	-28,900,000	184,100,000	7,100,000	-6,500,000	-51,700,000	239,800,000	41,700,000	155,400,000	1,300,000	280,800,000	-147,200,000	203,100,000	57,000,000	251,800,000	62,600,000	34,400,000	4,700,000	239,900,000	47,900,000	-25,100,000	-286,300,000	529,900,000	48,000,000	52,000,000	-15,600,000	418,500,000	47,400,000	31,000,000	-33,700,000	694,200,000	-378,000,000	-24,200,000	-17,300,000	1,131,600,000	97,000,000	110,200,000	881,500,000	98,100,000	63,600,000	787,100,000	70,300,000	84,900,000	476,900,000	29,300,000
proceeds from debt with original maturities of 90 days or less		-200,000	3,700,000				4,100,000
net financing (outflow) inflow from the accounts receivable facility			-13,300,000											1,400,000	-1,600,000					3,200,000	0
adjustments to reconcile net earnings to net cash flow from operations:
defined benefit settlement loss								700,000	0
changes in current assets and liabilities from operations, net of effects of acquisitions:
accounts receivable
inventories
other current assets
accounts payable
other current liabilities
acquisitions, net of cash acquired																												0	100,000			0	0	0	-34,000,000					0	-1,000,000	0	-11,100,000
proceeds from sale of infant care business
collection of deferred purchase price from accounts receivable sold
net cash used by investing activities				-25,500,000	-17,200,000	-13,700,000	-6,000,000	-18,900,000	-11,600,000	-8,800,000	-11,200,000	-17,800,000	-11,900,000	-13,000,000	-312,700,000									-18,600,000	-13,000,000			-20,200,000	-14,100,000			-11,100,000	-15,000,000	-10,800,000	-47,700,000	-18,600,000	-16,400,000	-20,000,000	-14,500,000	-24,700,000	-35,900,000	-89,600,000	-24,600,000	-15,900,000	-15,500,000	-202,100,000	-20,700,000	-22,200,000	-15,400,000	-24,500,000	-33,300,000	-2,600,000	-25,700,000
cash payments for debt with original maturities greater than 90 days
net proceeds from (payments for) debt with original maturities of 90 days or less
dividends paid to common shareholders
net financing inflow (outflow) from the accounts receivable facility										-4,000,000	8,800,000					1,600,000	100,000	-3,500,000	4,200,000								-5,100,000
net cash used by financing activities				-40,100,000	-79,900,000			-14,200,000				3,800,000				-5,500,000	-7,800,000	-46,600,000	-5,500,000	2,900,000				-6,300,000				-3,800,000	-121,700,000															-40,500,000			-102,100,000
net increase in cash and cash equivalents				13,000,000				9,000,000				7,100,000				41,700,000				-147,200,000							-26,500,000				27,000,000								-17,900,000	-378,000,000							98,100,000	63,600,000	68,600,000
supplemental disclosures of cash flow information:
cash paid for interest
cash paid for income taxes
proceeds from (payments for) debt with original maturities of 90 days or less
net cash used by operating activities							-72,900,000				-86,300,000			39,100,000	-79,000,000				-82,500,000				-46,900,000				-46,400,000				-21,000,000			58,600,000	-59,000,000				-58,700,000
cost of early retirement of long-term debt																0	0			0
cash proceeds from the issuance of senior notes due 2029																0	0
cash payments on senior notes due 2022																0	0
net increase in debt with original maturities of 90 days or less											5,500,000	400,000	-5,000,000	-700,000	1,400,000	1,800,000	1,700,000	-1,800,000	2,500,000	1,300,000	-700,000							-9,900,000	1,400,000			1,900,000	-1,100,000					-3,400,000	-2,200,000	17,900,000	-494,600,000	35,900,000	188,200,000	124,600,000	70,600,000	58,300,000	46,400,000	-57,100,000	131,100,000	5,300,000	-84,000,000	120,900,000
debt issuance costs for senior notes due 2029																0	-600,000
dividends paid
acquisition of billie, net of cash acquired													0	-600,000	-308,800,000
proceeds from sale of infant and pet care business													0	0	5,000,000		0	0	7,500,000		0	0	95,800,000
proceeds (payments) of debt with original maturities of 90 days or less
net cash from (used by) operating activities
(payments) proceeds of debt with original maturities of 90 days or less
net cash (used by) from financing activities																						5,400,000	-135,900,000										-67,300,000	-67,900,000	-199,400,000
gain on sale of infant and pet care business																				0	0	1,100,000	-5,200,000
investment in equity securities
cash proceeds from the issuance of senior notes due 2028																				0
cash payments on senior notes due 2021																				0
debt issuance costs for senior notes due 2028																				-1,300,000
debt issuance costs for the revolving credit facility																				0
acquisition of cremo																	0	0	-300,000
net cash from (used by) financing activities														-77,200,000	155,500,000																34,500,000
impairment charge																												0
proceeds from sale of other assets
term loan repayment																								0	0
net cash (used by) from investing activities																	-12,500,000	-11,300,000	-2,300,000								-2,900,000
net cash (used by) from operating activities
gain on sale of assets																									500,000	200,000	700,000
non-cash sun care reformulation costs
non-cash restructuring costs																																400,000	3,600,000	1,100,000	1,700,000	1,700,000	1,000,000	500,000	700,000	600,000	29,800,000				2,800,000	4,400,000	7,300,000	5,700,000	23,400,000
proceeds from sale of playtex gloves assets
common shares purchased																												0	0	-9,200,000	-115,200,000	-70,800,000	-36,100,000	-500,000	-58,000,000	-82,100,000	-35,600,000	0	-78,900,000
impairment charges
proceeds from sale of assets																								0	100,000	0	4,000,000	0	0	2,600,000	2,100,000	12,500,000	0							2,300,000	500,000	12,000,000	1,800,000	4,300,000	800,000	3,500,000	600,000	600,000	100,000	200,000	2,100,000	16,900,000	200,000
net cash from (used by) from investing activities																					-9,800,000	-8,600,000	89,700,000
net decrease in debt with original maturities of 90 days or less																							-100,000			4,400,000	-900,000				-1,300,000				-400,000
net financing outflow from the accounts receivable facility																							-14,900,000
(gain) loss on sale of assets
changes in current assets and liabilities used in operations, net of effects of business acquisitions:
playtex glove sale
net increase increase in debt with original maturities of 90 days or less
playtex gloves sale																													0	0	19,000,000
net increase (decline) in cash and cash equivalents
international pension funding																																				0	0
(gain) / loss on sale of assets																													600,000	300,000	-13,900,000
excess tax benefits from share-based payments																																									100,000	800,000	8,400,000	1,700,000	400,000	4,000,000	300,000	2,300,000	2,500,000	1,600,000	100,000	400,000	300,000
net cash from (used by) investing activities																															9,500,000
venezuela deconsolidation charge																																								0	0
change related to venezuelan operations																																								0	0
change in restricted cash																																								0	0
deferred finance expense																																				0				0
cash dividends paid																																								0	-31,100,000	-31,000,000	-31,100,000	-30,900,000	-30,800,000	-31,300,000	-24,900,000	-24,800,000	-24,800,000
transfer of cash and cash equivalents to new energizer
proceeds from issuance of common shares																																								0
changes in current assets and liabilities used in operations																																	35,700,000	-5,200,000	-118,700,000		16,500,000	1,800,000	-105,400,000		-29,100,000	23,500,000	-184,300,000	48,100,000	50,300,000	-149,000,000	81,100,000	40,800,000	-99,600,000
non-cash items included in income																																			-500,000	-9,900,000	-1,600,000	10,000,000	13,600,000	100,000	1,100,000	9,300,000	8,900,000	9,700,000	14,600,000	47,300,000	15,900,000	-11,400,000	75,900,000	54,800,000	58,400,000	54,600,000	68,000,000
net pension and postretirement gains
cash proceeds from issuance of debt with original maturities greater than 90 days																																								190,200,000
common stock purchased																																												0						-75,600,000	0	-135,900,000	0
proceeds from issuance of common stock																																										2,900,000	1,400,000	4,200,000	500,000	2,000,000	1,100,000	8,800,000	6,600,000	500,000	600,000	1,200,000	1,500,000
net cash from/(used by) financing activities																																																	8,900,000				-20,800,000
non-cash restructuring costs related to asset impairment/accelerated depreciation																																											1,400,000
net cash (used by)/from operating activities																																											-32,000,000
net increase/(decrease) in cash and cash equivalents																																											2,600,000							70,300,000	84,900,000	5,700,000
pension curtailment																																															0	0	-37,400,000
feminine care acquisition																																												-1,800,000	0	-185,300,000
net (decrease)/increase in cash and cash equivalents																																													110,200,000	-116,800,000							29,300,000
operating cash flow before changes in working capital																																															139,000,000	137,300,000	171,200,000	108,300,000	120,300,000	202,000,000	134,400,000
cash proceeds from issuance of debt with maturities greater than 90 days, net of discount
payment of debt issue cost
cash flow from operations
changes in current assets and liabilities used in operations, net of effects of business acquisition																																																		11,800,000	78,600,000	-174,200,000	-63,900,000
net cash from operations																																																		120,100,000			70,500,000
acquisition, net of cash acquired																																																					0
net cash (used by)/from financing activities																																																		-10,200,000	-84,800,000	-14,900,000
net sales
personal care																																																		22,000,000	87,100,000	564,400,000	114,900,000
household products																																																		300,000	-183,400,000	633,700,000	84,300,000
total net sales																																																		22,300,000	-96,300,000	1,198,100,000	199,200,000
operating profit
total operating profit																																																		-18,500,000	-74,900,000	272,300,000
general corporate and other incomes																																																		10,800,000	-6,900,000	-36,700,000	9,100,000
household products restructuring																																																		1,000,000	-10,700,000	9,200,000	15,700,000
acquisition inventory valuation
litigation provision
asr integration/transaction costs																																																		0	-900,000	-1,500,000
amortization																																																		200,000	-100,000	-5,700,000	200,000
venezuela devaluation/other impacts
cost of early debt retirements
interest and other financing items																																																		-4,200,000	-1,900,000	-29,200,000	-1,000,000
total earnings before income taxes																																																		-24,200,000	-95,400,000	208,400,000	39,900,000
net cash from/(used by) operations																																																				27,800,000
cash proceeds from issuance of debt with maturities greater than 90 days
net increase/(decrease) in debt with original maturities of 90 days or less																																																					-138,500,000
segment profit
total segment profit
asr transaction costs/integration																																																					-2,500,000
venezuela devaluation/non-operating impacts

We provide you with 20 years of cash flow statements for Edgewell Personal Care stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Edgewell Personal Care stock. Explore the full financial landscape of Edgewell Personal Care stock with our expertly curated income statements.

The information provided in this report about Edgewell Personal Care stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.